ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2191

Construct Validity of OMERACT Ultrasound Knee Scores with Pain, Other Symptoms, Radiographic and MRI Findings

Win Min Oo1, James Linklater 2, Kimberly Bennell 3, Shirley Yu 1, Xia Wang 1, Vicky Duong 1 and David Hunter 1, 1Rheumatology Department, Royal North Shore Hospital and Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Australia, Sydney, New South Wales, Australia, 2Department of Musculoskeletal Imaging, Castlereagh Sports Imaging Center, St. Leonards, Sydney, Australia, Sydney, New South Wales, Australia, 3Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, School of Health Sciences, Faculty of Medicine Dentistry & Health Sciences, The University of Melbourne, Melbourne, VIC, Australia., Parkville, Victoria, Australia

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: musculoskeletal sonography, Osteoarthritis, Validity and magnetic resonance imaging (MRI)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: To investigate the construct validity of Outcome Measures in Rheumatology (OMERACT) ultrasound scores for knee osteoarthritis (OA) with pain, other symptoms, and OA severity on radiographs and magnetic resonance imaging (MRI) counterparts.

Methods: A subgroup of community-recruited participants with symptomatic and mild-moderate radiographic knee OA participating in a randomized controlled trial of platelet-rich plasma were included in this study. At baseline, participants underwent dynamic ultrasound assessment using Aplio Platinum 500 machine, Toshiba, with a multi-frequency linear transducer (6-18MHz) according to the OMERACT scanning protocol. Using the published ultrasound image atlas by OMERACT group, a physician operator obtained semi-quantitative scores for synovitis, cartilage thinning, osteophytes and medial meniscal extrusion, and a dichotomous score for power Doppler (PD) signals, effusion and synovial hypertrophy. Clinical outcomes included the severity of pain on an 11-point numerical rating scale and Knee Injury and Osteoarthritis Outcome Score (KOOS) symptoms and pain sub-scores. The Likert responses of KOOS ranged from “none” to “extreme”. and scores ranged from 0 to 100, with lower scores indicating worse symptoms.  OA severity was assessed using the Kellgren-Lawrence grade (KLG) on plain radiograph. MRI osteoarthritis knee score (MOAKS) was used on non-contrast-enhanced MRI sequences to evaluate cartilage loss (any or full thickness) from patellofemoral, medial and lateral tibiofemoral compartments, osteophytes from 12 different sites, medial meniscal extrusion, effusion-synovitis and Hoffa’s synovitis. Linear regression was used to determine the associations of ultrasound OA pathologies with pain and KOOS sub-scores adjusting for confounders such as age, gender, disease duration and KLG as appropriate, and Spearman’s correlation was used for the relationship with KLG and MOAKS.

Results: Eighty-nine participants (female, 53.9%; body mass index, mean= 27.5±6.4) were included in the analysis. Synovial hypertrophy, PD signals and meniscal extrusion scores were associated with increased pain severity (B = 0.92, 95% confidence interval CI 0.25, 1.58); B = 0.73(95% CI 0.11, 1.35) and B = 1.01(95% CI 0.22, 1.80) respectively (Figure 1A). All ultrasound scores, except for cartilage grade, demonstrated associations with KOOS symptoms (Figure 1B) while only PD signals and meniscal extrusion were associated with KOOS pain (Figure 1C). All ultrasound scores, except for PD signals, were significantly correlated with KLG (Figure 2). Most ultrasound pathologies revealed moderate to good correlation with their MRI counterparts with ultrasound synovitis having the greatest correlation [0.69(95% CI 0.60, 0.78)] (Figure 3).

Conclusion: OMERACT ultrasound scores revealed good construct validity against commonly used measurement tools such as pain, function, and radiographic and MRI features, providing evidence to support its use as a standardized tool for determining ultrasound OA phenotypes.


Figure 1

Figure 1. The association of OMERACT ultrasound OA scores with -A- NRS pain -B- KOOS symptoms -C- KOOS pain


Figure 2

Figure 2. The association of OMERACT ultrasound OA scores with KLG on radiograph


Figure 3

Figure 3. The association of OMERACT ultrasound OA scores with MOAKS on magnetic resonance imaging


Disclosure: W. Oo, None; J. Linklater, None; K. Bennell, None; S. Yu, None; X. Wang, None; V. Duong, None; D. Hunter, Pfizer, 5, Lilly, 5, Merck Serono, 5, TLC bio, 5.

To cite this abstract in AMA style:

Oo W, Linklater J, Bennell K, Yu S, Wang X, Duong V, Hunter D. Construct Validity of OMERACT Ultrasound Knee Scores with Pain, Other Symptoms, Radiographic and MRI Findings [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/construct-validity-of-omeract-ultrasound-knee-scores-with-pain-other-symptoms-radiographic-and-mri-findings/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/construct-validity-of-omeract-ultrasound-knee-scores-with-pain-other-symptoms-radiographic-and-mri-findings/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology